Heidi Hagen

(Ms. Heidi Hagen)

Currently holds positions in ZIOPHARM Oncology Inc and Vericel Corp

Positions

Position Company Period
Director ZIOPHARM Oncology Inc June 13, 2019 -
Independent Director Vericel Corp Jan. 1, 2017 -
Director Vericel Corp Aug. 23, 2013 - Jan. 1, 2017
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-05 2025-03-03
US Vericel Corp (VCEL)
PS Planned sale
9,000 -23.9%
49.53
USD 445,770 		9,000 -23.9% 49.53 USD 445,770
// ... existing code ... // ... rest of the file ...